Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Squamous Cell Carcinoma of the Head and Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06725368
What this trial is testing

Carboplatin + Paclitaxel + Cetuximab (PCC) After Failure of Pembrolizumab +/- First-line Chemotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck Cancer
Centre Paul Strauss 46
Early research (Phase 1)Study completedNCT02110082
What this trial is testing

Combination Study of Urelumab and Cetuximab in Patients With Advanced/Metastatic Colorectal Cancer or Advanced/Metastatic Head and Neck Cancer

Who this might be right for
Colorectal CancerHead and Neck Cancer
Bristol-Myers Squibb 66
Early research (Phase 1)Study completedNCT03733210
What this trial is testing

Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer

Who this might be right for
Squamous Cell Carcinoma of the Head and NeckCarcinoma of the Head and Neck
Andrei Iagaru 14
Not applicableActive Not RecruitingNCT05338905
What this trial is testing

Intensive Symptom Surveillance Guided by Machine Learning-Directed Risk Stratification in Patients With Non-Metastatic Head and Neck Cancer, The INSIGHT Trial

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Roswell Park Cancer Institute 72
Large-scale testing (Phase 3)Study completedNCT00006481
What this trial is testing

Biafine Cream to Reduce Side Effects of Radiation Therapy in Patients Receiving Treatment for Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerSkin Reactions Secondary to Radiation Therapy
Radiation Therapy Oncology Group
Not applicableStudy completedNCT03244566
What this trial is testing

PET in Guiding Cervical Lymphadenectomy (ECTOP-2003)

Who this might be right for
Esophageal Cancer
Fudan University 110
Testing effectiveness (Phase 2)Study completedNCT04732494
What this trial is testing

Anti-PD-1 Monoclonal Antibody Tislelizumab (BGB-A317) Combined With or Without Anti-TIGIT Monoclonal Antibody Ociperlimab (BGB-A1217) in Participants With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
BeiGene 125
Early research (Phase 1)Study completedNCT00066651
What this trial is testing

Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors

Who this might be right for
Cervical CancerFallopian Tube CancerHead and Neck Cancer+5 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT06919666
What this trial is testing

NT219 Combined With Standard of Care Biologic Therapy in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell Carcinoma
University of Colorado, Denver 29
Testing effectiveness (Phase 2)Ended earlyNCT03347123
What this trial is testing

Epacadostat and Nivolumab in Combination With Immune Therapies in Participants With Advanced or Metastatic Malignancies (ECHO-208)

Who this might be right for
Solid Tumors
Incyte Corporation 11
Testing effectiveness (Phase 2)Study completedNCT01415674
What this trial is testing

Research of Biomarkers of Activity and Efficacy of BIBW2992 in Untreated Non-metastatic HNSCC Patients

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
UNICANCER 61
Testing effectiveness (Phase 2)Study completedNCT00030576
What this trial is testing

Erlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University Health Network, Toronto 51
Testing effectiveness (Phase 2)Study completedNCT03665285
What this trial is testing

A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid TumorsLung CancerBreast Cancer+6 more
NextCure, Inc. 109
Testing effectiveness (Phase 2)UnknownNCT00003326
What this trial is testing

Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Theradex 100
Not applicableUnknownNCT04543266
What this trial is testing

Predicting Metastatic Oral Squamous Cell Carcinomas With Molecular Biomarkers Using Machine Learning

Who this might be right for
Oral Squamous Cell Carcinoma
The University of Hong Kong 500
Early research (Phase 1)Looking for participantsNCT06022029
What this trial is testing

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Who this might be right for
Triple Negative Breast CancerDiffuse Large B Cell LymphomaFollicular Lymphoma+11 more
OncoNano Medicine, Inc. 168
Early research (Phase 1)Study completedNCT01637194
What this trial is testing

Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer

Who this might be right for
Recurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Colon Cancer+46 more
Fox Chase Cancer Center 12
Testing effectiveness (Phase 2)Ended earlyNCT04193293
What this trial is testing

Duvelisib in Combination With Pembrolizumab in Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma
SecuraBio 2
Testing effectiveness (Phase 2)Ended earlyNCT05814666
What this trial is testing

Activity and Safety of Danvatirsen and Pembrolizumab in HNSCC

Who this might be right for
HNSCC
Flamingo Therapeutics NV 69
Early research (Phase 1)Study completedNCT04413214
What this trial is testing

Carrimycin in Patients With Locally Advanced, Recurrent, or Metastatic HNSCC (Non NPC): A Phase I Trial

Who this might be right for
Oral Squamous Cell CarcinomaHead and Neck Squamous Cell Carcinoma
Shanghai Jiao Tong University School of Medicine 9
Next Page